Human papillomavirus infection
| カタログ | 製品 | 反応性 | アプリケーション | 引用 |
|---|---|---|---|---|
| DF6316 | ISG15 Ab | Human, Mouse, Rat | WB,IHC | 4 |
| AF3073 | P-p53 (Ser20) Ab | Human, Mouse, Rat | WB,IHC,IF/ICC | 3 |
| DF6423 | p21 Cip1 Ab | Human, Mouse, Rat | WB,IHC,IF/ICC | 3 |
| AF3438 | P-IRF3 (Ser386) Ab | Human, Rat | WB,IHC,IF/ICC | 2 |
| DF9042 | WNT7B Ab | Human, Mouse, Rat | WB,IHC,IF/ICC | 2 |
| AF3299 | P-STAT1 (Ser727) Ab | Human, Mouse, Rat, Monkey | WB,IHC,IF/ICC | 1 |
| DF6324 | KRAS Ab | Human, Mouse, Rat | WB,IHC | 1 |
| DF13275 | Laminin 2 alpha Ab | Human, Mouse, Rat | WB,IHC,IF/ICC | 1 |
| DF12538 | WNT2B Ab | Human, Mouse, Rat | WB,IF/ICC | 1 |
| BF8305 | AKT1 mAb | Human, Rat | WB | 1 |
| AF5264 | Collagen IV alpha 2 Ab | Human, Mouse, Rat | WB,IHC,IF/ICC | 0 |
| BF8111 | IKK-beta mAb | Human, Mouse, Rat | WB,IHC | 0 |
| BF8126 | PI3K p85/p55 mAb | Human, Mouse | WB,IHC | 0 |
| BF8134 | EGFR mAb | Human, Mouse | WB | 0 |
| BF8138 | PDGF Receptor beta mAb | Human | IHC | 0 |
| BF8160 | STAT1 mAb | Human, Mouse, Rat | WB,IHC | 0 |
| BF8191 | PKM2 mAb | Human, Mouse, Rat | WB | 0 |
| BF8244 | KAT3B/p300 mAb | Human | WB | 0 |
| BF8275 | FAS mAb | Human, Mouse, Rat | WB | 0 |
| AF8035 | P-MEK1/2 (Ser218+Ser222/Ser222+Ser226) Ab | Human, Mouse, Rat | WB,IHC,IF/ICC | 27 |
| AF8190 | P-TBK1 (Ser172) Ab | Human, Mouse, Rat | WB,IHC | 18 |
| DF2989 | P-beta Catenin (Ser33/Ser37/Thr41) Ab | Human, Mouse, Rat | WB,IF/ICC | 15 |
| AF1017 | Acetyl-NF-kappaB p65 (Lys310) Ab | Human, Mouse, Rat | WB,IHC,IF/ICC | 15 |
| AF6324 | p27 Kip1 Ab | Human, Mouse, Rat | WB,IF/ICC | 15 |
| AF0874 | NF-kB p65 Ab | Human, Mouse, Rat | WB,IHC,IF/ICC | 14 |
| AF0142 | Cyclin A Ab | Human, Mouse, Rat, Monkey | WB,IHC,IF/ICC | 14 |
| AF2305 | Acetyl-FOXO1A (Lys294) Ab | Human, Mouse, Rat, Monkey | WB,IHC | 14 |
| AF6259 | pan-AKT1/2/3 Ab | Human, Mouse, Rat, Monkey | WB,IHC,IF/ICC | 13 |
| AF1014 | P-ERK1/2 (Tyr204) Ab | Human, Mouse, Rat, Bovine | WB,IHC | 13 |
| AF3387 | P-NF-kB p65 (Ser276) Ab | Human, Mouse, Rat | WB,IHC,IF/ICC,IP | 13 |